Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | EYA2 | O00167 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27472350 | 0.98 | EYA2 (0.30) | TDP1EYA2APPACE | |
| SCHEMBL27861815 | 0.81 | TDP1 (0.32) | TDP1EYA2APPACEFFAR3 | |
| SCHEMBL3260596 | 0.80 | PLA2G2A (0.41) | TDP1TSHRALOX15BLMALDH1A1 | |
| SCHEMBL165060 | 0.78 | — | — | |
| SCHEMBL27700387 | 0.72 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL3076022 | 0.71 | SLC6A2 (0.33) | TSHRSLC6A2SLC6A4CYP2C19BLM | |
| SCHEMBL4013690 | 0.71 | — | — | |
| SCHEMBL3338460 | 0.70 | FFAR3 (0.38) | TDP1EYA2APPACEFFAR3 | |
| SCHEMBL8663088 | 0.70 | FFAR3 (0.38) | TDP1EYA2APPACEFFAR3 | |
| SCHEMBL27519289 | 0.70 | FFAR3 (0.38) | TDP1EYA2APPACEFFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210054018-A1 | TRANSFER RNA LIGAND ADDUCT LIBRARIES | GALEN BIOTECHNOLOGIES, LLC | 2021-02-25 | — | — | US | disclosed |
| EP-3403094-A1 | TRANSFER RNA LIGAND ADDUCT LIBRARIES | Galen Biotechnologies, LLC (US) | 2018-11-21 | — | — | EP | disclosed |
| WO-2017124034-A1 | TRANSFER RNA LIGAND ADDUCT LIBRARIES | GALEN BIOTECHNOLOGIES, LLC (US) | 2017-07-20 | — | — | WO | disclosed |
| EP-0874545-A1 | PLANT GROWTH REGULATOR FORMULATIONS AND PROCESS OF USING THE SAME | BASF CORPORATION (US) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997023130-A1 | PLANT GROWTH REGULATOR FORMULATIONS AND PROCESS OF USING THE SAME | BASF CORPORATION (US) | 1997-07-03 | — | — | WO | disclosed |
| WO-1997023133-A1 | LOW RATE APPLICATION OF INHIBITORS OF ETHYLENE BIOSYNTHESIS OR ACTION | BASF CORPORATION (US) | 1997-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210054018-A1 | TRANSFER RNA LIGAND ADDUCT LIBRARIES | NSUN3, TARBP1, TRDMT1 | TDP1 947/4885EYA2 4199/4885APP 3824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.